Editorial Comment to Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era.
Yasuyoshi MiyataTomohiro MatsuoPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)